Correction to: Leukemia (2016) 30, 1672–1681; doi:10.1038/leu.2016.69
Following the publication of this article, the authors have noted that three genes: FLT3, NRAS and ARID1A (each with mutational frequency of 5%) have been incorrectly labelled in Figure 4a showing the mutational landscape of APL relapse.
Below is the corrected figure.
The authors confirm that the above mislabeling has no impact on the conclusions made and wish to apologize for any inconvenience caused.
Additional information
The online version of the original article can be found at 10.1038/leu.2016.69
Rights and permissions
About this article
Cite this article
Madan, V., Shyamsunder, P., Han, L. et al. Erratum: Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia. Leukemia 30, 2430 (2016). https://doi.org/10.1038/leu.2016.237
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2016.237
This article is cited by
-
miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia
Annals of Hematology (2023)
-
Die akute Promyelozytenleukämie - ein hämatologischer Notfall
InFo Hämatologie + Onkologie (2022)
-
ARID1A has prognostic value in acute myeloid leukemia and promotes cell proliferation via TGF-β1/SMAD3 signaling
Clinical and Experimental Medicine (2022)
-
The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients
Annals of Hematology (2022)
-
Gene mutations in acute promyelocytic leukemia early death in patients treated with arsenic trioxide alone
Clinical and Translational Oncology (2021)